Investigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in @entity1 with XXXX .

@entity1 @entity1252 @entity262 @entity4155 @entity2132 @entity936 @entity941 @entity10632 @entity309 @entity4452
PURPOSE: To investigate the association between @entity936 ( @entity936 ) and serum levels of @entity4155 in @entity1 with systemic immune-mediated diseases. METHODS: @entity4155 and @entity4452 levels were measured in the sera of @entity1 whose tear production was <5 mm on the Schirmer test. Subjects included @entity1 with @entity2132 ( @entity2132 ), @entity309 ( @entity309 ), @entity10632 ( @entity10632 ), @entity1252 ( @entity1252 ), and no @entity262 . Corneal/conjunctival @entity941 staining was scored and the correlation between the score and the @entity4155 level was evaluated. RESULTS: A strong correlation existed between @entity4155 level and the type of @entity262 . @entity4155 was significantly elevated in @entity1 with chronic @entity2132 compared to those with @entity309 and @entity10632 . @entity4155 was not detectable in @entity1 with @entity1252 or in those without @entity262 . @entity4452 was not detected in any of the subjects. @entity4155 was significantly increased in @entity1 with high @entity941 staining scores. CONCLUSIONS: Our data suggest that @entity4155 is involved in the pathogenesis of @entity936 in @entity1 with systemic immune-mediated diseases.
